The Gameleya Institute believes that both Sputnik V and Sputnik Light will neutralize the latest Omicron variant and has started the necessary studies.

According to Kirill Dmitriev, CEO of the Russian Direct Investment Fund, “The Gamaleya Institute believes Sputnik V and Sputnik Light will neutralize Omicron as they have the highest efficacy against other mutations. In the unlikely case, a modification is needed, we will provide several hundred million Sputnik Omicron boosters by Feb 20, 2022."

Nonetheless the Gamaleya Institute, based on existing protocols of immediately developing vaccine versions for variants of concern, has already begun developing the new version of Sputnik vaccine adapted to Omicron.

In an unlikely case such modification is needed, the new Sputnik Omicron version can be ready for mass-scale production in 45 days. Several hundred million Sputnik Omicron boosters can be provided to international markets already by Feb 20, 2022, with over 3 billion doses available in 2022.

 According to a release issued by the RDIF, the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2 known to date. This has been demonstrated by an article published in Vaccines medical journal and international real-world data from numerous countries

The Sputnik vaccine's efficacy is based on the heterogeneous boosting approach using two different vectors for two shots, pioneered by the Gamaleya Institute, and a proven adenoviral vector platform, which triggers a broader immune response as compared to mRNA vaccines.